Wellness Update: Asia: Healthcare Sector concern: June 10, 2011 Swine Flu up in Asia

Healthcare Sector Update: June 10, 2011 | FINANCIAL NEWS NETWORK ONLINE: "BioCryst (NASDAQ:BCRX) is up after media reports said a novel variant of swine flu has emerged in Asia with a genetic adaptation giving some resistance to Roche's Tamiflu and GlaxoSmithKline's (NYSE:GSK) Relenza, the two mainstay drugs used to tackle the disease. However, there was no significant reduction in sensitivity to peramivir, an experimental flu drug from BioCryst."